ConductScience.org, home

Paper40314865

The evolving landscape of oncolytic virus immunotherapy: combinatorial strategies and novel engineering approaches.

Sheikh M and 3 others. Med Oncol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. The evolving landscape of oncolytic virus immunotherapy: combinatorial strategies and novel engineering approaches. Papers, record 40314865. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40314865

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The evolving landscape of oncolytic virus immunotherapy: combinatorial strategies and novel engineering approaches.
PubMed
Journal
Med Oncol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-11-03
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sheikh MMujibullah
2Saiyyad AArshiya
3Aliunui AAimé
4Jirvankar PSPranita S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Oncolytic VirotherapyMajor topic
NeoplasmsMajor topic
ImmunotherapyMajor topic
Oncolytic VirusesMajor topic
Humans
Animals
Tumor Microenvironment
Combined Modality Therapy

Source PubMed

Download CSV of topics

References157

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121276246Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.BMC Cancer2011https://conductscience.org/library/papers/21276246PubMed
229658163A Novel Oncolytic Herpes Capable of Cell-Specific Transcriptional Targeting of CD133± Cancer Cells Induces Significant Tumor Regression.Stem Cells2018https://conductscience.org/library/papers/29658163PubMed
319587709Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer.Gene Ther2009https://conductscience.org/library/papers/19587709PubMed
438543974Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth.Vaccines (Basel)2024https://conductscience.org/library/papers/38543974PubMed
537660142Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors.Cell Death Discov2023https://conductscience.org/library/papers/37660142PubMed
627154307Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.J Exp Clin Cancer Res2016https://conductscience.org/library/papers/27154307PubMed
730413828The clinical role of the TME in solid cancer.Br J Cancer2019https://conductscience.org/library/papers/30413828PubMed
832620755Cancer immunotherapy comes of age and looks for maturity.Nat Commun2020https://conductscience.org/library/papers/32620755PubMed
931350295The Tumor Microenvironment Innately Modulates Cancer Progression.Cancer Res2019https://conductscience.org/library/papers/31350295PubMed
1029157300Prospects for combined use of oncolytic viruses and CAR T-cells.J Immunother Cancer2017https://conductscience.org/library/papers/29157300PubMed
1133291506Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy.Cancers (Basel)2020https://conductscience.org/library/papers/33291506PubMed
1232722981BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains.Autophagy2021https://conductscience.org/library/papers/32722981PubMed
1335860357Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.Front Mol Biosci2022https://conductscience.org/library/papers/35860357PubMed
1439826543Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients.Cell2025https://conductscience.org/library/papers/39826543PubMed
1528929492Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer.Int J Cancer2018https://conductscience.org/library/papers/28929492PubMed
169242911Herpes simplex virus DNA replication.Annu Rev Biochem1997https://conductscience.org/library/papers/9242911PubMed
1739048823TMEFF1 is a neuron-specific restriction factor for herpes simplex virus.Nature2024https://conductscience.org/library/papers/39048823PubMed
1834903664Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34903664PubMed
1938702343Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38702343PubMed
2037641004The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.BMC Cancer2023https://conductscience.org/library/papers/37641004PubMed

See all 157 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41963598Apoptotic modulators enhance oncolytic virus-induced cytokine killing in acute myeloid leukaemia (AML).Br J Cancer2026https://conductscience.org/library/papers/41963598PubMed
41179287Reprogramming the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma: Therapeutic Targets and Innovations.Oncol Res2025https://conductscience.org/library/papers/41179287PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40314865

GET https://conductscience.org/api/papers/v1/40314865/references?page=2